Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus
- DOI
- 10.1016/j.jep.2026.122239
- Published
- 2027-01
- Container
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jep.2026.122239,
title = {Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus},
author = {Yi Su and Heng Yang and Xianru Gong and Jiahong Zhang and Yunhui Chen and Xianglong Li and Rui Peng and Zhima Zeji and Yulin Leng and Xiaoxu Fu},
year = {2027},
journal = {Journal of Ethnopharmacology},
doi = {10.1016/j.jep.2026.122239},
url = {https://doi.org/10.1016/j.jep.2026.122239}
}RIS
TY - JOUR TI - Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus AU - Yi Su AU - Heng Yang AU - Xianru Gong AU - Jiahong Zhang AU - Yunhui Chen AU - Xianglong Li AU - Rui Peng AU - Zhima Zeji AU - Yulin Leng AU - Xiaoxu Fu PY - 2027 JO - Journal of Ethnopharmacology DO - 10.1016/j.jep.2026.122239 UR - https://doi.org/10.1016/j.jep.2026.122239 ER -
APA
Su, Y., Yang, H., Gong, X., Zhang, J., Chen, Y., Li, X., Peng, R., Zeji, Z., Leng, Y., & Fu, X. (2027). Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2026.122239
Source records
- crossref · retrieved 2026-09-27T11:59:21.284Z